THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Jamie Miller

Concepts (209)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Critical Illness
12
2022
68
2.720
Why?
Analgesics, Opioid
8
2022
113
2.280
Why?
Ceftazidime
3
2022
15
2.180
Why?
Intensive Care Units, Neonatal
5
2022
58
1.830
Why?
Anti-Bacterial Agents
8
2022
523
1.520
Why?
Methadone
4
2019
17
1.470
Why?
Fentanyl
5
2021
34
1.470
Why?
Infant, Newborn
13
2022
873
1.410
Why?
Child
25
2022
2242
1.250
Why?
Neonatal Abstinence Syndrome
3
2019
10
1.100
Why?
Anti-Infective Agents
4
2017
80
1.100
Why?
Retrospective Studies
18
2023
2557
1.100
Why?
Infant
13
2022
996
1.050
Why?
Hypnotics and Sedatives
6
2022
29
1.030
Why?
Humans
49
2023
28121
1.010
Why?
Hyponatremia
3
2021
17
0.990
Why?
Gram-Negative Bacteria
3
2022
62
0.970
Why?
Ketamine
2
2022
10
0.880
Why?
Child, Preschool
13
2021
1137
0.820
Why?
Medication Therapy Management
2
2019
18
0.790
Why?
Cephalosporins
1
2022
18
0.780
Why?
Education, Pharmacy
2
2021
116
0.750
Why?
Dose-Response Relationship, Drug
9
2019
605
0.730
Why?
Meningitis
1
2020
11
0.700
Why?
Problem-Based Learning
1
2021
61
0.690
Why?
Tobramycin
2
2017
13
0.690
Why?
Metronidazole
2
2017
16
0.680
Why?
Streptococcal Infections
1
2020
35
0.680
Why?
Pharmacy Residencies
1
2020
6
0.670
Why?
Bacteremia
1
2020
80
0.660
Why?
Obesity
5
2023
668
0.660
Why?
Pharmacists
2
2022
73
0.660
Why?
Students, Pharmacy
2
2020
83
0.650
Why?
Pharmacy Service, Hospital
1
2019
14
0.650
Why?
Disease Management
2
2017
88
0.630
Why?
Substance Withdrawal Syndrome
5
2016
40
0.620
Why?
Drug Resistance, Bacterial
1
2019
42
0.620
Why?
Opioid-Related Disorders
4
2013
41
0.620
Why?
Analgesics
5
2016
38
0.610
Why?
Infant, Premature
2
2017
133
0.600
Why?
Extravasation of Diagnostic and Therapeutic Materials
1
2017
3
0.570
Why?
Hyaluronoglucosaminidase
1
2017
3
0.570
Why?
Amiodarone
1
2017
11
0.570
Why?
Anesthetics, Intravenous
1
2017
15
0.550
Why?
Anti-Arrhythmia Agents
1
2017
117
0.540
Why?
Microbial Sensitivity Tests
3
2022
148
0.520
Why?
Male
19
2020
13487
0.500
Why?
Aminoglycosides
1
2014
10
0.470
Why?
Hyperphosphatemia
1
2014
4
0.460
Why?
Pediatrics
3
2022
92
0.460
Why?
Amphotericin B
1
2014
19
0.450
Why?
Sodium Potassium Chloride Symporter Inhibitors
1
2014
4
0.450
Why?
Female
19
2020
15156
0.450
Why?
Drug Administration Schedule
6
2014
223
0.450
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
2
2019
10
0.450
Why?
Body Fluids
1
2014
18
0.450
Why?
Narcotic Antagonists
2
2011
32
0.450
Why?
Language Development
1
2013
4
0.440
Why?
Antifungal Agents
1
2014
67
0.430
Why?
Alkalosis
1
2013
2
0.430
Why?
Carbonic Anhydrase Inhibitors
1
2013
6
0.430
Why?
Acetazolamide
1
2013
9
0.430
Why?
Motor Skills
1
2013
34
0.430
Why?
Bumetanide
1
2012
2
0.400
Why?
Overweight
2
2011
111
0.390
Why?
Education, Pharmacy, Graduate
3
2022
18
0.390
Why?
Iatrogenic Disease
1
2012
14
0.380
Why?
Pharmaceutical Services
2
2022
41
0.370
Why?
Pharmacy
2
2022
34
0.370
Why?
Pruritus
1
2011
8
0.370
Why?
Infusions, Intravenous
4
2017
101
0.350
Why?
Cognition
1
2013
322
0.340
Why?
Cohort Studies
4
2022
886
0.340
Why?
Acute Kidney Injury
2
2023
74
0.340
Why?
2-Pyridinylmethylsulfinylbenzimidazoles
1
2009
9
0.330
Why?
Medication Errors
1
2009
26
0.320
Why?
Proton Pump Inhibitors
1
2009
27
0.320
Why?
Adolescent
7
2021
3123
0.310
Why?
Thrombocytopenia
1
2009
113
0.300
Why?
Otitis Media
1
2007
35
0.280
Why?
Clonidine
3
2016
10
0.240
Why?
Age Factors
2
2019
733
0.230
Why?
Vancomycin
2
2017
58
0.230
Why?
Respiration, Artificial
2
2022
42
0.230
Why?
Acyclovir
1
2023
8
0.210
Why?
Writing
2
2020
14
0.210
Why?
Educational Measurement
2
2021
128
0.200
Why?
Cefotaxime
1
2022
5
0.200
Why?
Monobactams
1
2022
6
0.200
Why?
Curriculum
3
2019
291
0.190
Why?
Bias
1
2022
42
0.190
Why?
Administration, Intravenous
2
2019
30
0.180
Why?
Hydromorphone
1
2021
7
0.180
Why?
Chlorothiazide
1
2021
3
0.180
Why?
Fatty Acids, Essential
1
2020
3
0.180
Why?
Sodium
1
2021
48
0.180
Why?
Adrenergic alpha-2 Receptor Agonists
3
2016
11
0.180
Why?
Ampicillin
1
2020
14
0.170
Why?
Streptococcus agalactiae
1
2020
11
0.170
Why?
Surgical Wound Dehiscence
1
2020
16
0.170
Why?
Narration
1
2020
20
0.170
Why?
Academic Medical Centers
2
2019
75
0.160
Why?
Surgical Wound Infection
1
2020
105
0.160
Why?
Research
1
2020
92
0.160
Why?
Internship and Residency
1
2022
239
0.160
Why?
Prognosis
1
2022
803
0.160
Why?
Employment
1
2019
49
0.160
Why?
Escherichia coli
1
2022
336
0.160
Why?
Gram-Negative Bacterial Infections
1
2019
22
0.160
Why?
Career Choice
1
2019
53
0.160
Why?
Drug-Related Side Effects and Adverse Reactions
1
2019
67
0.150
Why?
Coronary Disease
1
2019
119
0.150
Why?
Cross-Sectional Studies
2
2019
968
0.150
Why?
Acute Coronary Syndrome
1
2019
64
0.150
Why?
Injections, Intradermal
1
2017
2
0.140
Why?
Administration, Inhalation
1
2017
35
0.140
Why?
Drug Monitoring
1
2017
36
0.140
Why?
Cystic Fibrosis
1
2017
32
0.140
Why?
Clostridium Infections
1
2017
67
0.130
Why?
Adult
7
2023
7757
0.130
Why?
Patient Admission
1
2016
29
0.130
Why?
Water-Electrolyte Imbalance
1
2016
5
0.130
Why?
Arginine Vasopressin
1
2016
8
0.130
Why?
Vasoconstrictor Agents
1
2016
34
0.130
Why?
Shock
1
2016
17
0.130
Why?
Norwood Procedures
1
2016
13
0.120
Why?
Postoperative Care
1
2016
68
0.120
Why?
Vascular Diseases
1
2016
68
0.120
Why?
Amikacin
1
2014
4
0.120
Why?
Gentamicins
1
2014
15
0.120
Why?
Delayed-Action Preparations
1
2014
43
0.120
Why?
Pregnancy
1
2019
1181
0.120
Why?
Phosphorus
1
2014
53
0.110
Why?
Cardiac Surgical Procedures
1
2016
173
0.110
Why?
Infant, Very Low Birth Weight
1
2013
23
0.110
Why?
United States
1
2019
2149
0.100
Why?
Clinical Trials as Topic
2
2012
215
0.100
Why?
Regression Analysis
1
2013
210
0.100
Why?
Hemodynamics
1
2014
220
0.100
Why?
Practice Guidelines as Topic
1
2014
242
0.100
Why?
Time Factors
1
2017
1593
0.100
Why?
Adrenergic alpha-Agonists
2
2009
9
0.100
Why?
Conscious Sedation
1
2012
10
0.100
Why?
Analgesia
1
2012
13
0.100
Why?
Nursing Assessment
1
2012
27
0.100
Why?
Critical Care
1
2012
50
0.100
Why?
Longitudinal Studies
1
2013
413
0.100
Why?
Middle Aged
3
2019
7164
0.100
Why?
Drug Utilization
1
2012
28
0.100
Why?
Pain Management
1
2012
58
0.090
Why?
Quaternary Ammonium Compounds
1
2011
18
0.090
Why?
Naloxone
1
2011
19
0.090
Why?
Naltrexone
1
2011
19
0.090
Why?
Postoperative Complications
1
2016
613
0.090
Why?
Patient Discharge
1
2012
103
0.090
Why?
Pilot Projects
1
2012
432
0.080
Why?
Risk Factors
1
2014
2084
0.080
Why?
Hospitalization
1
2009
202
0.070
Why?
Quality of Life
1
2011
491
0.070
Why?
Drug Tolerance
2
2021
37
0.070
Why?
Chronic Disease
1
2007
273
0.070
Why?
Oklahoma
2
2020
1005
0.060
Why?
Fellowships and Scholarships
1
2022
39
0.050
Why?
Body Weight
1
2023
250
0.050
Why?
Intensive Care Units, Pediatric
1
2021
26
0.040
Why?
Intensive Care Units
1
2021
50
0.040
Why?
Medical Oncology
1
2022
94
0.040
Why?
Metabolic Clearance Rate
1
2019
18
0.040
Why?
Furosemide
1
2019
7
0.040
Why?
Self Efficacy
1
2019
77
0.040
Why?
Drug Prescriptions
1
2019
46
0.040
Why?
Occupations
1
2018
9
0.040
Why?
Feedback
1
2018
33
0.040
Why?
Computer Simulation
1
2019
230
0.040
Why?
Education
1
2018
33
0.040
Why?
Aged
2
2019
5416
0.040
Why?
Scholarly Communication
1
2018
4
0.040
Why?
Comorbidity
1
2019
256
0.040
Why?
Accreditation
1
2018
36
0.040
Why?
Leukocyte Count
1
2017
25
0.040
Why?
Program Development
1
2018
77
0.040
Why?
Healthcare Disparities
1
2019
92
0.040
Why?
Body Mass Index
1
2019
398
0.040
Why?
Diarrhea
1
2017
56
0.040
Why?
Learning
1
2018
97
0.030
Why?
Inpatients
1
2017
56
0.030
Why?
Registries
1
2019
386
0.030
Why?
Recurrence
1
2017
323
0.030
Why?
African Americans
1
2019
350
0.030
Why?
Risk Assessment
1
2019
611
0.030
Why?
Neutrophils
1
2017
181
0.030
Why?
Bronchodilator Agents
1
2016
15
0.030
Why?
Gastrointestinal Agents
1
2016
16
0.030
Why?
Adrenal Cortex Hormones
1
2016
75
0.030
Why?
Follow-Up Studies
1
2018
1014
0.030
Why?
Surveys and Questionnaires
1
2019
969
0.030
Why?
Aged, 80 and over
1
2019
2021
0.030
Why?
Opiate Substitution Treatment
1
2013
7
0.030
Why?
Psychomotor Agitation
1
2012
7
0.030
Why?
Pain Measurement
1
2012
166
0.020
Why?
Hospitals, Pediatric
1
2011
33
0.020
Why?
Anxiety
1
2012
146
0.020
Why?
Treatment Outcome
1
2017
2380
0.020
Why?
Reproducibility of Results
1
2013
773
0.020
Why?
Young Adult
1
2018
2731
0.020
Why?
Multivariate Analysis
1
2011
300
0.020
Why?
Logistic Models
1
2011
407
0.020
Why?
Dexmedetomidine
1
2009
2
0.020
Why?
Animals
1
2009
10399
0.010
Why?
Miller's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (209)
Explore
_
Co-Authors (33)
Explore
_
Similar People (55)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES